![logo](/logos/ORGS.webp)
Orgenesis Inc.
NASDAQ:ORGS
0.59 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Orgenesis Inc. |
Symbool | ORGS |
Munteenheid | USD |
Prijs | 0.59 |
Beurswaarde | 27,686,281 |
Dividendpercentage | 0% |
52-weken bereik | 0.25 - 1.08 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Ms. Vered Caplan M.Sc. |
Website | https://www.orgenesis.com |
An error occurred while fetching data.
Over Orgenesis Inc.
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)